Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The widely used anti-diabetes and weight loss drug Mounjaro, which contains the active ingredient tirzepatide, is now ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

These hormones help regulate blood sugar, control appetite, and slow digestion, making patients feel full for longer. Mounjaro’s dual action on GLP-1 and GIP receptors sets it apart from Ozempic ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? In one corner, we’ve got Mounjaro®, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help patients with ...

Amy Schumer opened up about taking the weight loss drug Mounjaro after previously ‘horrible experience’ while on Wegovy.

The dual action mechanism sets Mounjaro apart from older GLP-1 receptors like Ozempic (semaglutide)—potentially making it more effective for both blood sugar control and weight loss.